Highlights related to macular degeneration from the American Society of Retina Specialists (ASRS) Annual Meeting 2023
News and articles
By ClearSight, 5 August, 2023
IZERVAY, a new complement C5 inhibitor, is now FDA-approved for treating GA due to AMD. Studies showed a reduction in the rate of GA growth and risk of vision loss.
Tags
By ClearSight, 27 July, 2023
While sunlight's blue light may harm the eyes, there is no evidence for screen-emitted blue light. Protect from sunlight and practice good eye habits.
Tags
By ClearSight, 24 July, 2023
No clinical study demonstrated blue light emitted by digital screens was harmful. Encouraging healthy digital device use habits, putting on sunglasses, and going outside and play are more beneficial than getting blue-light-blocking glasses.
Tags
By ClearSight, 20 July, 2023
An appropriate amount of TV doesn’t cause myopia or its progression, but poor TV habits can contribute to digital eye strain.
By ClearSight, 17 July, 2023
Drusen are common in aging adults over the age of 50. While drusen alone don't signify macular degeneration, people with larger or numerous drusen have an increased risk.
Tags
By ClearSight, 13 July, 2023
LASIK for presbyopia using monovision can provide clear vision without glasses or contact lenses, offering a significant improvement for adaptable individuals, despite potential drawbacks.
Tags
By ClearSight, 9 July, 2023
Presbyopia and myopia are refractive errors. Presbyopia affects near vision, myopia affects distance vision. Other differences include prevalence, age of onset, and anatomical abnormality.